XYLONEURAL sol inj s cons 5 amp 5 ml
7680427730181
CH-42773
N01BB02
01.02.2.
1 / 3
google
Details
- Product number
- 4277301
- CPT
- -
- Packaging group
- 5 x 5 mL
- Unit
- Ampulle(n)
- Composition
- lidocaini hydrochloridum anhydricum 10 mg ut lidocaini hydrochloridum monohydricum, natrii chloridum, natrii hydroxidum, aqua ad iniectabilia, q.s. ad solutionem pro 1 ml corresp. natrium 3.56 mg.
Articles (1)
Xyloneural, Injektionslösung
Injektionslösung
5 x 5 mL
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
lidocaini hydrochloridum anhydricum
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
lidocaini hydrochloridum monohydricum
|
- | Substance | WIZUS |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
3.56 MG | Substance | HBESI |
Authorization holder
Gebro Pharma AG
4410 Liestal
Authorization information
- Swissmedic authorization number
- 42773
- Drug name
- Xyloneural, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- N01BB02
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- B
- First authorization
- 15/01/1981
- Authorization expiration date
- 31/07/2025
- IT number
- 01.02.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- XYLONEURAL sol inj s cons 5 amp 5 ml
- Description (DE)
- XYLONEURAL Inj Lös o Kons 5 Amp 5 ml
- Market launch
- 15/01/1981
- Market withdrawal
- 31/07/2025
- Narcotic (BTM)
- No